Symposium 4 Inhibitors to Clotting Factors

[SY4-5] Acquired von Willebrand syndrome

Masaki Hayakawa¹, Hisanori Horiuchi², Koichi Kokame³, Tomoyuki Yambe⁴, Yasuyuki Shiraishi⁴, Akihiro Yamada⁴, Yusuke Inoue⁴, Yoshikatsu Saiki⁵, Teruhito Yasui⁶, Takeharu Minamitani⁶, Masanori Matsumoto¹ (1.Transfusion Medicine Division, Nara Medical University, Japan, 2.Department of Molecular and Cellular Biology, Institute of Development, Aging and Cancer, Tohoku University, Japan, 3.Department of Molecular Pathogenesis, National Cardiovascular Centre Research Institute, japan, 4.Department of Medical Engineering and Cardiology, Institute of Development, Aging and Cancer Tohoku University, japan, 5.Department of caddiovascular surgery, Tohoku University Graduate School of Medicine, Japan, 6.Laboratory of Infectious Diseases and Immunity, National Institutes of Biomedical Innovation, Health and Nutrition, Japan)

Experiences and Educations
2003 M.D. Respiratory and Hematology medicine, Nara Medical University
2005 Tenri city hospital, Nara
2011 Department of Transfusion Medicine, Nara Medical University
Fellowship Award
2016 Japan Cardiovascular Research foundation
"Novel strategy for diagnosis and therapy of acquired vonWillebrand syndrome"
Honors and Awards
2011 Abstracts award, XXIII International society of Thrombosis Hemostasis Congress
2014 Presentation award, 62st congress of the Japan society of Transfusion and cell therapy
2016 Abstract achievements, American society of hematology Annual meeting